AAAAAA

   
Results: 1-25 | 26-45

Table of contents of journal:

Results: 1-25/45
Adaptive immunity
Authors: Unanue, ER
Citation: Er. Unanue, Adaptive immunity, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 3-17
Innate immunity and instruction of the adaptive immune response
Authors: Fearon, DT
Citation: Dt. Fearon, Innate immunity and instruction of the adaptive immune response, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 18-27
Cyclophosphamide
Authors: Steinberg, AD
Citation: Ad. Steinberg, Cyclophosphamide, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 31-50
The purine antagonists: Azathioprine and mycophenolate mofetil
Authors: Tolkoff-Rubin, NE Rubin, RH
Citation: Ne. Tolkoff-rubin et Rh. Rubin, The purine antagonists: Azathioprine and mycophenolate mofetil, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 51-64
Methotrexate
Authors: Weinblatt, ME
Citation: Me. Weinblatt, Methotrexate, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 65-80
Immunosuppressants and immunophilin binding agents: Current research and clinical applications
Authors: Baksh, S Friedman, J Burakoff, SJ Bierer, BE
Citation: S. Baksh et al., Immunosuppressants and immunophilin binding agents: Current research and clinical applications, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 81-102
Glucocorticoid action
Authors: Miner, JN Brown, M
Citation: Jn. Miner et M. Brown, Glucocorticoid action, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 103-116
Cyclooxygenase inhibitors
Authors: Smith, WL DeWitt, DL
Citation: Wl. Smith et Dl. Dewitt, Cyclooxygenase inhibitors, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 117-131
Antileukotrienes (leukotriene modifiers) in the treatment of asthma
Authors: Drazen, JM
Citation: Jm. Drazen, Antileukotrienes (leukotriene modifiers) in the treatment of asthma, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 132-139
Phosphodiesterase inhibitors
Authors: Cooper, N Krishna, MT Gristwood, R Holgate, S
Citation: N. Cooper et al., Phosphodiesterase inhibitors, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 140-149
Tryptase inhibitors
Authors: Walls, AF
Citation: Af. Walls, Tryptase inhibitors, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 150-158
5-aminosalicylic acid (mesalamine) and sulfasalazine
Authors: MacDermott, RP
Citation: Rp. Macdermott, 5-aminosalicylic acid (mesalamine) and sulfasalazine, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 159-167
Antihistamines (H-1-receptor antagonists)
Authors: Simons, FER
Citation: Fer. Simons, Antihistamines (H-1-receptor antagonists), THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 168-176
Hematopoietic growth factors
Authors: Sieff, CA
Citation: Ca. Sieff, Hematopoietic growth factors, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 179-200
Cytokines regulating immune inflammation: Interleukin-4, interleukin-10, and interleukin-12
Authors: Mitchell, RN Abbas, AK
Citation: Rn. Mitchell et Ak. Abbas, Cytokines regulating immune inflammation: Interleukin-4, interleukin-10, and interleukin-12, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 201-219
The interferons: Basic biology and therapeutic potential
Authors: Shankaran, V Schreiber, RD
Citation: V. Shankaran et Rd. Schreiber, The interferons: Basic biology and therapeutic potential, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 220-239
Interleukin-2 immunostimulation
Authors: Smith, KA
Citation: Ka. Smith, Interleukin-2 immunostimulation, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 240-250
A soluble TNF receptor-Fc fusion protein (etanercept) in the treatment of inflammatory diseases
Authors: Widmer, MB Garrison, L Mohler, KM
Citation: Mb. Widmer et al., A soluble TNF receptor-Fc fusion protein (etanercept) in the treatment of inflammatory diseases, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 251-263
Intravenous immunoglobulin therapy
Authors: Bonilla, FA Geha, RS
Citation: Fa. Bonilla et Rs. Geha, Intravenous immunoglobulin therapy, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 264-286
Therapeutic inhibition of complement activation with emphasis on drugs in clinical trials
Authors: Klickstein, LB Moore, FD Atkinson, JP
Citation: Lb. Klickstein et al., Therapeutic inhibition of complement activation with emphasis on drugs in clinical trials, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 287-301
Treatment of angioedema resulting from Cl-inhibitor deficiency
Authors: Waytes, AT Rosen, FS
Citation: At. Waytes et Fs. Rosen, Treatment of angioedema resulting from Cl-inhibitor deficiency, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 302-312
Inhibitors of tumor necrosis factor
Authors: Kavanaugh, AF Lipsky, PE
Citation: Af. Kavanaugh et Pe. Lipsky, Inhibitors of tumor necrosis factor, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 313-326
Targeting the IL-2 receptor with antibodies or chimeric toxins
Authors: Strom, TB
Citation: Tb. Strom, Targeting the IL-2 receptor with antibodies or chimeric toxins, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 327-331
Monoclonal antibodies to CD3
Authors: Chatenoud, L
Citation: L. Chatenoud, Monoclonal antibodies to CD3, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 332-341
Anti-IgE: Immunotherapy for allergic diseases
Authors: MacGlashan, D
Citation: D. Macglashan, Anti-IgE: Immunotherapy for allergic diseases, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 342-351
Risultati: 1-25 | 26-45